In association with Fish & Richardson. With US and China being increasingly the main dominant source of investment for life science companies, how should companies balance their engagement? Furthermore, how do the broader US-China relations impact the flow of investment into other markets, such as the UK.
Mike Ward, Global Head of Thought Leadership, Clarivate (Moderator)
Chad Shear, Principal, Fish & Richardson
Simon Haworth, CEO, Dynasty Bio
Hayley French, CEO, Apitope
Yuehua Cong, Executive Director, Head of BD&L and Strategic Investment Management, Simcere Pharmaceutical Group
Delegates have the option of attending online or in-person, but not in the traditional hybrid format, as follows: